10x Genomics Inc.
Organization details
- Legal name
- 10x Genomics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 3826 — Laboratory Analytical Instruments
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Pleasanton
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TXG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001770787
- EIN
- 45-5614458
Board of directors
-
Alan Mateo · DirectorSince 2024
-
Ansuman Satpathy · DirectorSince 2026
-
Benjamin J. Hindson · Director · See RemarksSince 2023
-
Bryan E. Roberts · DirectorSince 2023
-
John R. Stuelpnagel · DirectorSince 2023
-
Joseph E. Gilliam · DirectorSince 2026
-
Kimberly J. Popovits · DirectorSince 2023
-
Mathai Mammen · DirectorSince 2023
-
Sarah A. Teichmann · DirectorSince 2024
-
Serge Saxonov · Director · Chief Executive OfficerSince 2023
-
Shehnaaz Suliman · DirectorSince 2023
-
Sridhar Kosaraju · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
86.6%
-
90.7%
-
91.3%
Board connections
4 of this board's directors also sit on 6 other boards.
- via Joseph E. Gilliam
- via Kimberly J. Popovits
- via Kimberly J. Popovits
- via Mathai Mammen
- via Kimberly J. Popovits
- via Shehnaaz Suliman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $16,876,550
- 50 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −1,000 | $78.23 | $78,230 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −292 | $78.20 | $22,834 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −2,000 | $79.62 | $159,240 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −614 | $79.51 | $48,819 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −9,300 | $80.90 | $752,370 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −1,325 | $80.82 | $107,087 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −9,900 | $81.83 | $810,117 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −2,270 | $81.67 | $185,391 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −2,800 | $82.37 | $230,636 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −1,222 | $82.28 | $100,546 |
| Sep 9, 2026 | Taich Adam Officer (Chief Financial Officer) | Open-market sale | −1,206 | $63.68 | $76,798 |
| Sep 9, 2026 | Taich Adam Officer (Chief Financial Officer) | Open-market sale | −31,428 | $64.31 | $2,021,135 |
| Sep 9, 2026 | Taich Adam Officer (Chief Financial Officer) | Open-market sale | −13,754 | $65.26 | $897,586 |
| Sep 3, 2026 | John R. Stuelpnagel Director | Open-market sale | −7,012 | $60.66 | $425,348 |
| Sep 3, 2026 | John R. Stuelpnagel Director | Open-market sale | −6,814 | $62.11 | $423,218 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about 10x Genomics Inc.
Who is the CEO of 10x Genomics Inc.?
Serge Saxonov is 10x Genomics Inc.'s Chief Executive Officer.
How many directors are on 10x Genomics Inc.'s board?
10x Genomics Inc.'s board has 12 directors: Alan Mateo, Ansuman Satpathy, Benjamin J. Hindson, Bryan E. Roberts, John R. Stuelpnagel, Joseph E. Gilliam, Kimberly J. Popovits, Mathai Mammen, Sarah A. Teichmann, Serge Saxonov and 2 others.
Are 10x Genomics Inc. insiders buying or selling shares?
Over the last 12 months, 10x Genomics Inc. insiders made no open-market purchases and sold $16.9 million of shares in 50 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="10x-genomics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.